Blood grouping reagents Market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report gives historical, current, and future market sizes (US$ Mn) on the basis of product, technique, test type, end user and region. This report market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global market report include suppliers, manufacturers, marketers, policy makers, and service providers engaged in Blood grouping reagents.
Blood grouping reagents are the essential testing reagents which are used by hospitals and the blood banks for the determination and identification of antibody type in patient’s and donors blood, in order to ensure the effective and safe transfusion of blood and to reduce the risks causing infections. Blood grouping reagents are indicated for determination of the Rh type and ABO blood group from donor’s blood. Blood grouping reagents are made up of antibodies which are derived from in-vitro cultures of hybridomas of human and murine origin and also includes antigens to act against blood groups A, B, A & B, D, Anti-C, Anti-c, Anti-E, Anti-e, and Anti-K for ABO typing.